These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 11478737

  • 21. Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.
    Schmeer C, Obregón F, Urbina M, Lima L.
    Neurochem Res; 2001 Mar; 26(3):213-23. PubMed ID: 11495544
    [Abstract] [Full Text] [Related]

  • 22. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
    Nénonéné EK, Radja F, Carli M, van Gelder NM, Afkhami-Dastjerdian S, Reader TA.
    Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242
    [Abstract] [Full Text] [Related]

  • 23. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA.
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [Abstract] [Full Text] [Related]

  • 24. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 25. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 26. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 17; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 27. [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain.
    Fabre V, Boni C, Mocaër E, Lesourd M, Hamon M, Laporte AM.
    Eur J Pharmacol; 1997 Oct 22; 337(2-3):297-308. PubMed ID: 9430429
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B.
    Brain Res; 1995 Nov 06; 698(1-2):146-54. PubMed ID: 8581473
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X, Ennis C, Minchin MC.
    Life Sci; 1997 Nov 06; 60(9):653-65. PubMed ID: 9048968
    [Abstract] [Full Text] [Related]

  • 32. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J, Lakoski JM.
    Brain Res; 1996 Jul 22; 728(1):130-4. PubMed ID: 8864308
    [Abstract] [Full Text] [Related]

  • 33. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neurochem Int; 1997 Jun 22; 30(6):565-74. PubMed ID: 9152998
    [Abstract] [Full Text] [Related]

  • 34. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse.
    Patel S, Hutson PH.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):197-204. PubMed ID: 8997601
    [Abstract] [Full Text] [Related]

  • 35. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y, Kimura I, Watanabe Y, Yamada J.
    Biol Pharm Bull; 2001 Oct 19; 24(10):1191-4. PubMed ID: 11642331
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.